Mirum Pharmaceuticals, Inc.
NASDAQ:MIRM
41.56 (USD) • At close December 27, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 90.377 | 77.875 | 69.222 | 69.554 | 47.725 | 37.497 | 31.598 | 27.906 | 18.78 | 17.484 | 12.892 | 3.138 | 5 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 20.806 | 20.227 | 17.83 | 22.604 | 10.228 | 6.812 | 4.979 | 4.494 | 2.932 | 2.524 | 2.424 | 1.903 | 0 | 0 | 0.185 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 69.571 | 57.648 | 51.392 | 46.95 | 37.497 | 30.685 | 26.619 | 23.412 | 15.848 | 14.96 | 10.468 | 1.235 | 5 | 11 | -0.185 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.77 | 0.74 | 0.742 | 0.675 | 0.786 | 0.818 | 0.842 | 0.839 | 0.844 | 0.856 | 0.812 | 0.394 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 31.71 | 32.672 | 32.222 | 30.841 | 26.117 | 22.009 | 23.548 | 31.105 | 26.217 | 25.432 | 24.088 | 27.775 | 30.471 | 35.048 | 38.134 | 29.726 | 15.984 | 18.555 | 17.34 | 14.38 | 12.159 | 11.589 | 4.863 | 25.229 | 0.003 |
| General & Administrative Expenses
| 0 | 41.237 | 0 | 39.884 | 0 | 32.949 | 0 | 16.957 | 0 | 20.969 | 0 | 19.035 | 17.353 | 13.353 | 9.479 | 7.225 | 5.732 | 5.042 | 4.692 | 4.278 | 3.708 | 2.445 | 1.321 | 0.806 | 0.062 |
| Selling & Marketing Expenses
| 0 | 7.971 | 0 | 6.3 | 0 | 5.685 | 0 | 9.511 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 50.545 | 49.208 | 45.638 | 46.184 | 36.528 | 32.949 | 30.219 | 26.468 | 22.513 | 20.969 | 19.116 | 19.035 | 17.353 | 13.353 | 9.479 | 7.225 | 5.732 | 5.042 | 4.692 | 4.278 | 3.708 | 2.445 | 1.321 | 0.806 | 0.062 |
| Other Expenses
| 0 | 0 | 1.757 | 46.015 | 1.322 | -49.35 | -0.811 | -0.588 | -0.192 | 1.299 | -0.154 | 107.983 | -0.035 | -0.514 | -0.016 | -0.083 | -0.03 | -0.056 | -0.023 | -0.02 | -0.005 | 0.009 | -0.005 | 0 | 0 |
| Operating Expenses
| 82.255 | 81.88 | 77.86 | 77.025 | 62.645 | 54.958 | 53.767 | 57.573 | 48.73 | 46.401 | 43.204 | 46.81 | 47.824 | 48.401 | 47.613 | 36.951 | 21.716 | 23.597 | 22.032 | 18.658 | 15.867 | 14.034 | 6.184 | 26.034 | 0.065 |
| Operating Income
| -12.684 | -24.232 | -26.468 | -30.075 | -25.148 | -24.273 | -27.148 | -34.161 | -32.882 | -31.441 | -32.736 | -45.575 | -42.824 | -37.401 | -47.613 | -36.951 | -21.716 | -23.597 | -22.032 | -18.658 | -15.867 | -14.034 | -6.184 | -4.299 | -0.065 |
| Operating Income Ratio
| -0.14 | -0.311 | -0.382 | -0.432 | -0.527 | -0.647 | -0.859 | -1.224 | -1.751 | -1.798 | -2.539 | -14.524 | -8.565 | -3.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -1.204 | 0.229 | 1.813 | -2.849 | 1.809 | -49.449 | -2.781 | -2.13 | -2.811 | -2.051 | -3.859 | 103.133 | -4.275 | -6.482 | -2.914 | -0.25 | 0.207 | 0.349 | 0.726 | 0.727 | 0.78 | 0.477 | 0.227 | -21.646 | -0.002 |
| Income Before Tax
| -13.888 | -24.003 | -24.655 | -32.924 | -23.339 | -73.722 | -29.929 | -36.291 | -35.693 | -33.492 | -36.595 | 57.558 | -47.099 | -43.883 | -50.527 | -37.201 | -21.509 | -23.248 | -21.306 | -17.931 | -15.087 | -13.557 | -5.957 | -25.945 | -0.067 |
| Income Before Tax Ratio
| -0.154 | -0.308 | -0.356 | -0.473 | -0.489 | -1.966 | -0.947 | -1.3 | -1.901 | -1.916 | -2.839 | 18.342 | -9.42 | -3.989 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.347 | 0.635 | 0.624 | 0.225 | 0.249 | 0.316 | 0.201 | 0.14 | 0.013 | -6.57 | 0.011 | 0.012 | 0.009 | 0.011 | 0.005 | 0.002 | -0.003 | 0.003 | 0.004 | 0.021 | -0.785 | -0.468 | 0.232 | -21.646 | -0.065 |
| Net Income
| -14.235 | -24.638 | -25.279 | -33.149 | -23.588 | -74.038 | -30.13 | -36.431 | -35.706 | -26.922 | -36.606 | 57.546 | -47.108 | -43.894 | -50.532 | -37.203 | -21.506 | -23.251 | -21.31 | -17.952 | -15.087 | -13.557 | -5.957 | -25.945 | -0.067 |
| Net Income Ratio
| -0.158 | -0.316 | -0.365 | -0.477 | -0.494 | -1.975 | -0.954 | -1.305 | -1.901 | -1.54 | -2.839 | 18.338 | -9.422 | -3.99 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.3 | -0.52 | -0.54 | -0.71 | -0.57 | -1.94 | -0.8 | -0.99 | -1.02 | -0.84 | -1.17 | 1.88 | -1.55 | -1.45 | -1.68 | -1.43 | -0.86 | -0.93 | -0.86 | -0.79 | -0.84 | -0.59 | -0.6 | -9.52 | -0.007 |
| EPS Diluted
| -0.3 | -0.52 | -0.54 | -0.71 | -0.57 | -1.94 | -0.8 | -0.97 | -1.02 | -0.84 | -1.17 | 1.88 | -1.55 | -1.45 | -1.68 | -1.43 | -0.86 | -0.93 | -0.86 | -0.79 | -0.84 | -0.59 | -0.6 | -9.52 | -0.007 |
| EBITDA
| -4.247 | -14.58 | -15.414 | -26.377 | -17.103 | -68.514 | -24.206 | -30.603 | -30.518 | -28.912 | -32.378 | 61.761 | -41.254 | -38.932 | -46.961 | -36.701 | -21.354 | -23.101 | -21.15 | -18.599 | -15.83 | -14.034 | -5.925 | -21.646 | -0.002 |
| EBITDA Ratio
| -0.047 | -0.187 | -0.223 | -0.355 | -0.527 | -1.867 | -0.766 | -1.168 | -1.625 | -1.667 | -2.511 | 20.048 | -8.522 | -3.424 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |